Results per Page:
When it comes to low-affinity HER2 CAR T cells, less is more
From the Riddell lab, Translational Science and Therapeutics Division and Cancer Immunology Program
Multiple myeloma research to be presented at American Society of Hematology annual meeting
Dr. Rahul Banerjee to share insights on reducing financial toxicity, time toxicity and side effects of treatment
Common genetic disorder linked to increased death rate from cancer drug
Researchers recommend ‘caution’ when using the chemotherapy busulfan in patients with Gilbert’s syndrome
Transplanted gene-modified blood stem cells protect brain cancer patients from toxic side effects of chemotherapy
Study is first to show feasibility and efficacy of a new use for autologous stem cell transplant